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Abstract 
Introduction 
The substrate location and underlying electrophysiological mechanisms that contribute to the characteristic ECG 
pattern of Brugada Syndrome (BrS) are still debated. Using non-invasive electrocardiographical imaging (ECGi), 
we studied whole heart conduction and repolarization patterns during ajmaline challenge in BrS individuals. 
Methods and Results 
13 participants (mean age 44±12 yrs; 8 males), 11 concealed Type I BrS patients and 2 healthy controls, 
underwent an Ajmaline infusion with ECGI and ECG recordings. ECGi activation recovery intervals (ARI) and 
activation timings across the right ventricle (RV) body, outflow tract (RVOT), and left ventricle (LV) were 
calculated and analysed at baseline and when Type I BrS pattern manifested following ajmaline. Peak J-ST point 
elevation was calculated from the surface ECG, and compared to the ECGi derived parameters at the same time 
point. 
 
Following ajmaline infusion, the RVOT had the greatest increase in conduction delay (5.4±2.8ms vs 2.0±2.8ms vs 
1.1±1.6ms; p=0.007) and ARI prolongation (69±32ms vs 39±29ms vs 21±12ms; p=0.0005) compared to RV or LV. 
In controls, there was minimal change in J-ST point elevation, conduction delay or ARI at all sites with ajmaline. 
In BrS patients, conduction delay in RVOT, but not RV or LV, correlated to the degree of J-ST point elevation 
(Pearson R 0.81, p<0.001). No correlation was found between J-ST point elevation and ARI prolongation in the 
RVOT, RV or LV. 
Conclusion 
Magnitude of ST (J point) elevation in the Type I BrS pattern is attributed to degree of conduction delay in the 
RVOT and not prolongation in repolarization time. 
 
 
Key words: Brugada Syndrome, Non-invasive Electrocardiographical Imaging (ECGi), Repolarisation, 
Depolarisation, Sodium Channel Blockade 
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Introduction 
Both abnormalities in repolarization and depolarization have been described in BrS, although 
which of these mechanisms give rise to the ST segment elevation (STE) in the Type I pattern 
remain unclear1. The varying degree of STE observed within different BrS subjects likely 
reflects different degrees of conduction and/or repolarization heterogeneity in the epicardial 
right ventricular outflow tract (RVOT), as suggested by previous clinical studies2-4.  
Body surface mapping potential and echocardiographic surrogates of conduction over the RV, 
but not repolarization, have been found to correlate with STE following sodium channel 
blockade in BrS2,3. In contrast, single contact electrode data from electrophysiological 
catheters situated in the epicardial and endocardial RVOT demonstrated that STE 
corresponded to prolongation of repolarization in the epicardial RVOT following pilsicainide4. 
Currently, high density, epicardial data characterising the relationship of STE to changes in 
conduction and repolarization is lacking. 
Electrocardiographical imaging (ECGi) is a novel tool that utilises body surface potentials from 
a 252-electrode vest, and using inverse solution mathematics, reconstructs >1200 unipolar 
electrograms onto a digitised epicardial heart surface. It is possible to observe patterns of 
depolarization and repolarization using this method and it has also been used to study the 
electrophysiological substrate in a variety of conditions5,6. 
In this study, we aimed to characterise whole heart electrophysiological conduction and 
repolarization patterns on the epicardial surfaces of BrS hearts following ajmaline infusion. 
We also correlated these changes to the degree of J point elevation of the ST segment on the 
surface ECG to further elucidate the mechanisms that underlie the Type I ECG in BrS.  
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Methods 
Subject enrolment 
Patients referred to our centre for an Ajmaline challenge for suspected Brugada Syndrome 
were recruited. Individuals were referred for the test as part of a family screen or based on 
clinical history and ECG findings. All patients were required to withhold all concurrent 
medications 5 days before the test. 
Study protocol 
ECGi (EcVUE system, Medtronic) and 15 lead surface ECG recordings were simultaneously 
performed at resting baseline and throughout the ajmaline challenge. The ECGi methodology 
has been described and validated previously7. Briefly, body surface potential data obtained 
via a 252-electrode vest was combined with patient specific heart-torso geometry derived 
from a thoracic CT scan. Using inverse solution mathematical algorithms, the ECGi system 
reconstructed epicardial unipolar electrograms (EGM) and panoramic activation maps over a 
single sinus beat which was visualised on a digitised image of the patient’s heart (Figure 1a). 
A total ajmaline dose of 1mg/kg was administered and infused over a period of 5 minutes. 
The infusion was prematurely stopped in the event of manifestation of the Type 1 BrS pattern 
or prolongation of the QRS interval by 130%. Recordings were discontinued once the 15 lead 
ECG had returned to baseline, or for a period of at least 20 minutes where no ECG changes 
were observed. The study protocol was reviewed and approved by our institutional review 
committee (ref:14/LO/1318). All subjects gave informed consent.  
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Changes in activation time duration from ECGi  
3-D activation maps were automatically generated from the ECGi system and are based on 
local activation timings (LAT), defined as the steepest negative deflection (-dV/dt) during the 
QRS complex, of the unipolar EGM. Activation maps were generated at baseline and following 
ajmaline (at manifestation of BrS pattern in responders or end of infusion in non-responders) 
and the activation timing window of interest were synchronised to allow comparison across 
phases. Activation maps over three consecutive beats were checked at each phase to ensure 
consistency. Analysis and detection of differences in activation patterns across the phases 
was carried out by two of the reviewers and where interpretation differed a third reviewer 
arbitrated. A surrogate for right ventricular outflow tract (RVOT), right ventricular (RV) and 
left ventricular (LV) free walls activation time duration (ATD) was derived from the difference 
in EGM local activation time between two points, 3.5 centimetres apart, in the direction of 
the activation wavefront within their respective regions pre-ajmaline. This was compared to 
the RVOT, RV and LV ATD derived from the same locations post ajmaline. Anatomical 
landmarks on CT scan were used to define the regions: - i) left anterior descending artery 
separated the RV and LV, ii) the outflow tract was defined as the region within the RV 4cm 
below the pulmonary valve. An example of ATD measurement in the RVOT is shown in Figure 
2.  
Activation recovery intervals from ECGi unipolar EGMs 
For each patient, the left and right ventricles were anatomically divided into 15 regions 
(Figure 1b), from which 45 unipolar EGMs (3 per region) were analysed during a cardiac cycle 
at each of the following phases: - i) pre-ajmaline ii) post-ajmaline. EGM analysis was 
performed using an off-line semi-automated custom-made programme with Matlab 
(Mathworks Inc, USA). Activation recovery interval (ARI), a surrogate of action potential (AP) 
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duration or index of myocardial repolarization time, was taken from the LAT to the steepest 
negative deflection (-dV/dt) of a positive T wave, or the steepest positive deflection (+dV/dt) 
of a negative or biphasic T wave of the unipolar EGM (Figure 1b)8. As ARI vary with heart rate, 
values were corrected using the Bazett’s formula (ARIc). Changes in both ARI and ARIc in the 
RVOT, RV and LV following ajmaline were subsequently computed. Changes in RVOT 
transepicardial ARI/ARIc dispersion were also calculated which was defined as the maximum 
difference between ARI/ARIc values within this region. A detailed ARI map of the RVOT region 
was also derived to illustrate the changes in response to ajmaline in one patient. As such an 
electroanatomical map could not be automatically produced by the EcVUE version of the ECGi 
system, ARI was individually derived from over 100 points within the RVOT region before and 
after ajmaline. Contour maps were subsequently created using a graphical software package 
(Surfer 13, Golden Software LLC, Colorado) with the data obtained.   
 
15 lead surface ECG analysis 
Tpeak-end duration (Tped) reflects transmural dispersion of repolarization and was calculated 
in the precordial leads as shown in figure 1c using digital calipers by a reviewer blinded to 
patient details9. Manifestation of the Type I BrS pattern (J point elevation ≥2mm within the 
coved ST segment and negative T wave in ≥1 precordial RV lead) was confirmed by 2 study 
investigators on the 15 lead ECG10. The J point was defined as the junction between the end 
of the QRS complex and the beginning of the ST-segment11. J point elevation was the distance 
in millimetres from the isoelectric baseline determined with digital calipers (figure 1c). The ST 
segment at 40ms (ST40) and 80ms (ST80) from this point was also obtained. The time point at 
which the diagnostic BrS pattern became evident on the 15 lead ECG was noted and 
simultaneously corroborated on the ECGi system. Changes in conduction (ATD) and 
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repolarization (ARI/ARIc) derived from the ECGi system were studied between the two 
phases: i) pre-ajmaline and ii) post-ajmaline – at the point when Type I BrS pattern manifest. 
In cases where the ajmaline challenge yielded a negative result, the post-ajmaline phase was 
taken at the 6 minute point following commencement of the infusion. For each patient, the 
maximal J point and ST (J-ST) elevation from the precordial leads was calculated from the 
surface ECG using digital calipers. Maximal J-ST point elevation was correlated with the 
amount of change in ATD, ARI/ARIc and Tped in each region.  Changes in Tped within RV/RVOT 
region is represented by the lead with maximal J-ST point elevation within V1 and V2 in the 
2nd, 3rd and 4th intercostal spaces, and lead V5 for the LV. As transepicardial dispersion of 
repolarization also exists in the BrS phenotype, J-ST point elevation was also correlated with 
the change in RVOT ARI/ARIc transepicardial dispersion. 
Statistical Analysis 
Changes in ATD, ARI/ARIc and Tped from baseline were calculated for the RVOT, RV and LV in 
each individual, with pooled mean change and standard deviation presented for each 
anatomical region. Difference between the three regions in mean change in ATD and ARI/ARIc 
following ajmaline were compared using a one-way ANOVA. The Newman-Keuls multiple 
comparison test was utilized in the post-hoc analysis if ANOVA was significant. Where a two 
-group comparison of continuous variables was appropriate, the unpaired t-test was 
employed. Correlation was calculated using Pearson’s correlation coefficient. Statistical 
analysis was performed using GraphPad PRISM v5 (Graphpad Software Inc, USA), and a p 
value of <0.05 was considered significant.  
 
Results 
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Patient characteristics 
Thirteen patients underwent Ajmaline challenge with ECGi and 15 lead surface ECG 
recordings (mean age 44±12 years; 8 males). Eleven of these had a Type I BrS pattern induced 
on the surface ECG. A positive diagnosis was reached between 1.5 to 6 minutes of the 
ajmaline infusion. Manifestation of the Type I pattern occurred within leads V1 and V2 in the 
2nd, 3rd and 4th intercostal spaces. No ventricular arrhythmias were induced during the 
infusion. Table 1 summarises the clinical characteristics of all participants. Two patients (12 
and 13) had BrS excluded following a negative Ajmaline challenge and served as controls in 
the study. 
Effect of Ajmaline on whole heart activation pattern 
A representative example of 3D activation map before and after ajmaline in a BrS patient is 
shown (Figure 2a). Conduction slowing within the RVOT, as evidenced by greater amount of 
isochronal crowding or increase in ATD between two fixed points, can be observed after the 
appearance of the Type I BrS pattern following ajmaline. In all 11 BrS patients, an increase in 
ATD was preferentially seen in the RVOT compared to the RV and LV (5.4±2.8ms vs 2.0±2.8ms 
vs 1.1±1.6ms; ANOVA p=0.0007) (Figure 2b). In contrast, no significant differences were 
observed between the RVOT, RV and LV in the controls (2.1±0.1ms vs 1.5±0.7ms vs 1.0±1.4ms; 
ANOVA p=0.58).  
Effect of Ajmaline on EGM morphology and whole heart repolarization 
Alterations in EGM morphology were observed in BrS patient and not in controls. 
Representative examples of EGMs are shown before and after ajmaline in a BrS and control 
patient (Figures 3a i and ii). Manifestation of coved ST segment elevation along with negative 
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T wave could be observed in EGMs restricted to the RVOT region (Figure 3ai), although no 
such changes were observed in the control patient (Figure 3aii). ARI was observed to 
preferentially prolong in the RVOT region in comparison to the RV and LV (39±32ms vs 
12±30ms vs 2±19ms; ANOVA p=0.0056) (Figure 3b). A similar picture was observed with ARIc 
(69±32ms vs 39±29ms vs 21±12ms; ANOVA p=0.0005). In the controls, no differences in 
ARI/ARIc prolongation between regions were observable (ANOVA p=0.50 and p=0.45 
respectively).  
The mean increase in Tped was similarly larger in leads over the RVOT/RV than LV in the BrS 
group (19±7 vs 1±2; p=0.004) (Table 2). Prolongation in Tped in the RV lead, where maximal 
ST elevation was observed, was larger than the LV lead (V5) (21±18ms vs 2±13ms, p=0.013). 
No significant difference was observed between the RV/RVOT and LV for controls following 
ajmaline (2±3ms vs 1±0.5ms, p=0.512) 
Correlation of ATD, ARI/ARIc and Tpeak-end duration with J-ST point elevation 
To investigate the effect changes in conduction and repolarization within the epicardial RVOT 
have on J point elevation following ajmaline, we correlated change in ATD and ARI/ARIc with 
maximal J point elevation. A strong correlation was observed between increase in ATD in the 
RVOT and J point elevation (Pearson R=0.81, p=0.0009) (Figure 4a) but not in the RV (R=0.27, 
p=0.36) and LV (R=0.21, p=0.49), where a 1mm increase in J point elevation equated to an 
increase in ATD by 1.44±0.32ms in the RVOT. In addition, there was no significant correlation 
between ARI/ARIc prolongation and J point elevation in any region (ARI - RVOT: R=0.33, 
p=0.27; RV: R=-0.08, p=0.79; LV: R=-0.07, p=0.82) (ARIc - RVOT: R=0.51, p=0.07; RV: R=0.13, 
p=0.66; LV: R=0.40, p=0.18) (Figure 4b). J point elevation was also not observed to correlate 
with Tped changes in any of the RV/RVOT and LV leads (Table 2). No significant correlation to 
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J elevation was also observed when compared to Tped changes in the RV lead where maximal 
J elevation was observed (Figure 4c).  
Transepicardial heterogeneity of the AP duration, or dispersion of ARI/ARIc, may exist within 
the RVOT in BrS. At baseline, there was a higher but non-significant difference in ARI 
dispersion in BrS patients when the BrS ECG was not manifest (35±27ms vs 13±5; p=0.3). 
Following ajmaline, ARI dispersion within the RVOT was greater in BrS patients than controls 
(58±22ms vs 17±6ms; p=0.04). This was similar for ARIc dispersion. Figure 5a illustrates the 
prolongation and increase in ARI gradients within the RVOT in a BrS patient following 
ajmaline. We correlated the changes in RVOT dispersion with J point elevation but did not 
find a significant relationship using ARI (R=0.20, p=0.50) or ARIc (R=0.20, p=0.52) (Figure 5b). 
Similar results were observed when correlated with ST40 and ST80 elevation (Table 3). 
Discussion 
In this study, we describe the changes in conduction and action potential duration in non-
spontaneous BrS human hearts in-vivo following ajmaline. Greater changes were observed in 
the RVOT than RV or LV re-affirming the site of the pathological substrate in this condition. 
Importantly, we demonstrated a correlation between J point elevation in the Type I BrS 
pattern and increasing conduction delay in the epicardial RVOT which further supports the 
depolarization hypothesis as the underlying electrophysiological mechanism of the Type I 
pattern seen.   
Differences in the RVOT, RV and LV in BrS 
Although the genetic abnormalities implicated in BrS affect individual ion channel functioning 
across the heart uniformly, the RVOT has been shown to be the site of the electrophysiological 
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substrate that gives rise to the BrS phenotype12. One explanation, likely lies in differences 
during embryonic development and ion channel expression between the RVOT, RV and LV13. 
Thus, it is of interest to determine the differential behaviour of the RVOT, RV and LV to sodium 
channel blockade, although few studies have examined the electrophysiological changes in 
these regions simultaneously in patients with non-spontaneous Type I pattern2,3,14.  
Body surface potential mapping data in BrS patients following ajmaline, has previously shown 
a significant increase in body surface filtered QRS duration in the precordial leads overlying 
the RV but not the LV2. Differences between the RV and RVOT were not commented upon 
owing to the methodological limitations in knowing the corresponding body surface 
potentials of the RV and RVOT. Another whole heart study employing ECGi in patients with a 
spontaneous Type I pattern showed that steeper repolarization gradients and higher mean 
activation durations were preferentially found in the RVOT compared to RV or LV within BrS 
subjects at resting baseline5. These studies, in addition to previous intracardiac 
electrophysiological mapping studies restricted to the RV/RVOT, support our findings that 
changes in conduction and repolarization following ajmaline predominantly affects the RVOT 
in comparison to RV or LV in the BrS heart14-16.  
Changes in conduction and J-ST elevation 
Increase in ATD was most prominent in the RVOT and did not differ much between the RV 
and LV free wall (Figure 3) in the BrS patients. The embryonic RVOT differs in embryological 
origin to the LV and loses its slow conducting properties much later than the RV and LV during 
its development. It is purported that remnants of the embryonic outflow tract are present, as 
supported by findings of fibrosis and the presence of late potentials in the RVOT in a 
transplanted BrS heart17. Combined with genetic defects which alter the current available for 
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AP propagation (e.g. inward sodium (INa)), initiation of the AP in the RVOT occurs much later 
than the RV. The depolarization hypothesis considers that delayed activation in the RVOT, 
relative to the RV, creates an electrotonic gradient which gives rise to the ST elevation 
observed on the body surface electrodes over this region. It would thus follow that the 
magnitude of J-ST point elevation would correlate with the degree of activation delay in the 
RVOT, and not the RV or LV as confirmed in our results. Our findings are also similar to 
previous studies that have correlated filtered QRS duration from body surface mapping 
potentials and right ventricular conduction delay from echocardiography to ST elevation on 
the surface ECG2,3. Change in ATD observed in our study is relatively small and seemingly 
associated with large changes in J-ST elevation. It should be pointed out these measurements 
only reflect changes in conduction over a selected epicardial area, and may act as a surrogate 
for larger absolute changes in conduction that occur transmurally or across the entire 
myocardium18.  
Changes in epicardial repolarization with J-ST point elevation 
In the repolarization hypothesis, transmural dispersion created by a more notched AP and 
longer APD from cells in the epicardium than endocardium is proposed to give rise to the ST 
elevation seen and is supported mainly by experimental data1. In one clinical study, ARIc from 
unipolar EGMs in the endocardial and epicardial RVOT were measured during 
electrophysiological catheter studies in nineteen BrS subjects4. Following sodium channel 
blockade with pilsicainide in nine individuals, Nagase et al reported a prolongation in ARIc in 
the epicardial RVOT but no change in the endocardium and reported this occurrence on 
manifestation with the BrS phenotype4. In contrast, other studies compared body surface 
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mapping potential and echocardiographic surrogates of repolarization with ST elevation 
following ajmaline and flecainide respectively, but found no correlation in either study2,3. 
Similar to Nagase et al, we have observed prolongation of ARI/ARIc in the epicardial RVOT 
occurring with the onset of the BrS phenotype. In addition, we demonstrate that ARIc 
prolongation occurs preferentially over this region compared to the RV and LV. However, we 
also show that changes in repolarization on the RVOT epicardium do not correlate with the 
degree of J point and ST elevation following sodium channel blockade. It should be pointed 
out that ECGi does not provide EGM data from the endocardium, and it is assumed that the 
changes to transmural dispersion following sodium channel blockade arise mainly from the 
ARIc prolongation in the RVOT epicardium, as previously shown by Nagase and colleagues. 
Another surrogate of transmural dispersion of repolarization is the Tped9. Although a 
preferential increase in Tped occurred over the RV/RVOT region in BrS patients, there was no 
significant correlation with J point elevation. However, it has also been suggested that Tped 
from the surface ECG may reflect regional dispersion rather than transmural which limits the 
interpretation of our findings19.  
Prolongation of ARI/ARIc may also be related to the blocking effects of ajmaline on the 
transient potassium outward current (Ito)20. The greater prolongation in the whole RV 
(including RVOT) of ARI/ARIc than LV is in keeping with there being a smaller Ito channel 
density in the LV (ARI: 25±25ms vs -2±19ms; p<0.01) (ARIc: 54±20ms vs 21±12ms; p<0.01)13. 
The differences between the RV and RVOT are less clear and may relate to a differential 
distribution density of Ito channels in these regions. Interestingly, little change was observed 
within the RVOT and RV in the controls. Nagase and colleagues similarly observed no 
significant changes in ARIc in the RVOT in their three controls following pilsicainide. It is 
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possible that these differences in ARI prolongation observed between BrS and controls may 
relate to the amount of functioning Ito channels available which would support the notion that 
non-SCN5a genetic mutations are also implicated in this syndrome1.  
Although we have not observed a correlation between J point or ST elevation with surrogates 
of transmural or transepicardial ARI dispersion, it may be premature to completely discount 
the repolarization hypothesis as a fundamental assumption has been made with ARI 
measurements. ARI derived from the unipolar EGM assumingly reflects a single AP duration 
as employed in several previous studies4,5,12,14-16. In a pharmacological wedge preparation 
model of BrS, Szel and Antzelevitch demonstrate that ‘notching’ within the ST segment 
observed in the unipolar EGM signal in BrS could relate to a second AP caused by concealed 
phase 2 re-entry. In these EGMs, the T wave is proposed to be related to the second 
depolarization21 and ARI measurements may thus produce an erroneous result. In Figure 3ai, 
comparison has been made to the ‘notching’ observed in the coved ST segment of the 
unipolar ECGi EGM from the RVOT. Whilst we have no monophasic action potential data to 
determine if phase 2 re-entry is occurring in our patients, previous work has shown the 
presence of singular monophasic action potentials in the RVOT epicardium in BrS human 
studies12,22. We therefore assume the validity of using ARI to reflect APD as with other work 
in the literature4,5,12,14-16.  
 
Limitations 
The number of controls in our study is small. However, the aim of this study was to correlate 
ST elevation and changes in depolarization and repolarization rather than to compare 
differences in BrS and normal hearts. Both our controls did not manifest the Type I pattern 
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despite receiving the full weight adjusted dosage of ajmaline, and provide important control 
points to this correlation study. It is also unclear what effects age, gender and individual 
genetic mutations have on this relationship between conduction delay and ST elevation. 
Evidence exists on the differences in ion channel distribution between the genders and age 
has an impact on conduction in SCN5a+ murine hearts20,23. The number of BrS cases in this 
study limits our ability to provide answers to these questions.  
The RVOT studied is assumed to be the region encompassing the area four centimetres below 
the pulmonary valve as identified from the CT scan, and may have possibly included a small 
part of the RV at the junction of the outflow tract. The ATD examined within the heart only 
reflects specific areas within the RV and LV free wall. This was limited by being able to obtain 
the same measurement points along the activation wave fronts at baseline and following 
ajmaline. We believe that main regions of interest were studied and little additional 
information would be obtained by breaking the regions down further which are also fraught 
with other methodological difficulties. 
Our study is also restricted to those with a concealed Type I BrS pattern and does not include 
any with a spontaneous Type I pattern for comparison. Although we are conducting a 
separate study in the latter group, an advantage of studying the concealed BrS group with 
ajmaline allows for each subject to serve as their own baseline control. Inter-individual 
variability in conduction and repolarization at baseline exists and would require a much larger 
number of patients with a spontaneous Type I pattern and varying ST elevation to derive any 
correlative data.  
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Conclusion 
The strength of our study is in providing in-vivo epicardial whole heart and regional changes 
in conduction, repolarization and EGM morphology in response to ajmaline. More 
importantly, we demonstrate the underlying significance of the magnitude of ST elevation 
seen in the BrS pattern on the surface ECG. Our findings that conduction delay or excitation 
failure in the RVOT, and not prolongation of epicardial action potential duration, correlates 
with the BrS pattern provides further support for the depolarization hypothesis. 
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Table 1 – Group characteristics. V1 and V2 are in the right and left 4th intercostal space (IC) 
respectively. IC2 – 2nd intercostal space. IC3 – 3rd intercostal space. 
s/no Gender Age Ajmaline 
Result 
Maximal  J point 
elevation (mm) 
Type I 
pattern in 
Lead(s) 
Previous 
SCD 
event 
Time to 
positive 
ajmaline 
(mins) 
1 M 33 + 5 V2IC3 - 6 
2 M 40 + 2.5 V1IC2 - 5 
3 M 39 + 3 V1IC2; V2IC3 + 6 
4 F 69 + 2 V1 - 6 
5 M 32 + 2 V1IC2 - 5 
6 M 50 + 4 V2 + 6 
7 M 52 + 4 V2; V2IC3 + 5 
8 F 50 + 5 V2 - 5 
9 F 60 + 2.2 V1 - 6 
10 M 36 + 4 V2IC3 - 1.5 
11 F 50 + 2 V1 - 5 
12 M 38 - 0 V1 - n/a 
13 F 25 - 0.4 V1 - n/a 
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Table 2 – Tpeak-end duration at baseline and following ajmaline 
Region Leads 
Brugada 
Syndrome 
Control 
Correlation of Tpe 
change to J 
elevation 
  
Baseline 
(ms) 
Ajmaline 
(ms) 
Baseline 
(ms) 
Ajmaline 
(ms) 
Pearsons 
R 
p value 
RV/ 
RVOT 
 
V1 (IC2) 82±10 104±23 81±4 84±7 0.26 0.39 
V2 (IC2) 93±16 98±19 79±5 82±9 -0.24 0.43 
V1 (IC3) 83±13 107±25 74±7 79±5 0.37 0.22 
V2 (IC3) 90±17 110±26 86±23 91±21 0.32 0.29 
V1 85±16 109±18 60±11 65±9 0.57 0.06 
V2 96±16 112±13 95±1 95±3 -0.02 0.95 
Lead with max 
J elevation 
85±15 106±20 60±11 61±12 0.44 0.13 
        
LV 
V4 95±11 95±14 75±5 77±7 -0.10 0.75 
V5 94±11 96±14 75±5 76±6 -0.01 0.99 
V6 89±12 87±11 77±7 77±7 0.06 0.85 
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Table 3 – Correlation to ST40 and ST80 following ajmaline 
ATD change Correlation to ST40 p value Correlation to ST80 p value 
RVOT 0.84 0.0003 0.91 0.0001 
RV 0.27 0.37 0.25 0.41 
LV 0.24 0.43 0.35 0.24 
     
ARI prolongation     
RVOT 0.41 0.16 0.41 0.16 
RV -0.79 0.78 -0.11 0.73 
LV 0.05 0.87 0.12 0.69 
     
Change in RVOT ARI 
dispersion  
0.29 0.34 0.33 0.28 
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Figure Legends 
Figure 1: (a) ECGi system combining body surface potential data from a 252-electrode vest (i 
& ii) with CT derived heart-torso geometry (iii & iv) to produce epicardial unipolar 
electrograms and panoramic 3D electroanatomical maps (v). (b) The heart is anatomically 
divided into 15 segments with examples of unipolar electrograms in three regions shown. (c) 
Shows position of electrode of 15 lead ECG recording and measurement of J elevation and 
Tpeak to end duration.  
Figure 2: (a) 3D activation maps of epicardial breakthrough during a sinus beat before and 
after ajmaline infusion, at maximal J point elevation, in a patient with BrS. Close up of the 
RVOT (red box) shows greater isochronal crowding, with corresponding delay in electrogram 
local activation timing at site 1, following ajmaline infusion. (b) Mean±SD changes in 
activation time duration in the RVOT, RV and LV are shown with the largest increase in the 
RVOT following ajmaline in BrS patients. ** p<0.01; *** p<0.001; ns – not significant. 
Figure 3: (a) Changes in unipolar electrogram morphology in a BrS patient (i) and control (ii) 
following ajmaline. In the BrS patient, there is coving and T wave inversion following ajmaline 
in EGMs within the RVOT region but no change in EGM morphology in the RV or LV. ARI in the 
RVOT region are subsequent prolonged. In contrast, there is little change in morphology or 
ARI in the control patient despite the full ajmaline dose administered. (b) Mean ARI 
prolongation is greatest in the RVOT compared to the RV or LV in BrS patients. * p<0.05; ** 
p<0.01; ns – not significant. 
Figure 4: (a) Correlation between maximal J point elevation following ajmaline and the 
corresponding changes in ATD in the RVOT at the same time point for all patients. (b) 
Correlation between maximal J point elevation following ajmaline and the corresponding ARIc 
prolongation in the RVOT at the same time point for all patients. (c) Correlation between 
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maximal J point elevation following ajmaline and the Tped changes in the RVOT/RV lead with 
maximal J elevation at the same time point for all patients. 
Figure 5: (a) ARI map in the RVOT region of a BrS patient at baseline and following 
manifestation of the BrS pattern with ajmaline. One observes prolongation of ARI within the 
RVOT, and increase in maximal gradient or dispersion of ARI with ajmaline. (b) Maximal 
dispersion of ARI is correlated with J point elevation (and ST segment elevation – table 3) 
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